Literature DB >> 25997508

Protoporphyrin IX formation after topical application of methyl aminolaevulinate and BF-200 aminolaevulinic acid declines with age.

C V Nissen1, P A Philipsen1, H C Wulf1.   

Abstract

BACKGROUND: Topical photodynamic therapy (PDT) is a popular treatment modality in dermatology. The effect of PDT in epidermal cells depends on formation of protoporphyrin IX (PpIX) from 5-aminolevulinic acid (ALA). A variety of physiological changes in epidermal function occur with increasing age, but no studies have investigated whether PpIX formation is age-related.
OBJECTIVES: To investigate a possible relationship between age and PpIX formation.
METHODS: Methyl aminolaevulinate cream (MAL) and 5-ALA gel (BF-200 ALA) were applied to two identical fields on the forearm of 30 healthy volunteers for 24 h. The volunteers were divided into two age groups: a young group under 55 years (range 18-54) and an older group over 55 years (range 65-85). PpIX formation was measured noninvasively every hour from 1-5 h, and after 18, 21 and 24 h. Skin phototype, stratum corneum hydration and ultraviolet (UV) damage were also assessed. Treatment efficacy in relation to age was evaluated in 100 basal cell carcinomas (BCCs) treated with MAL-PDT.
RESULTS: Both photosensitizers induced significantly more PpIX formation in the younger group. Linear regression revealed a significant age-related decline in PpIX formation after the standard application time of 3 h (P < 0.001 for both treatments). Skin phototype, stratum corneum hydration and UV damage were not associated with PpIX formation. The treatment efficacy of BCCs 3 months after MAL-PDT was higher in young patients (P =  0.012).
CONCLUSIONS: PpIX formation in human skin declines with age. No explanation could be attributed to skin phototype, stratum corneum hydration or UV damage. The consequence might be reduced efficacy of PDT in the elderly.
© 2015 British Association of Dermatologists.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25997508     DOI: 10.1111/bjd.13923

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  4 in total

Review 1.  Combined Treatments with Photodynamic Therapy for Non-Melanoma Skin Cancer.

Authors:  Silvia Rocío Lucena; Nerea Salazar; Tamara Gracia-Cazaña; Alicia Zamarrón; Salvador González; Ángeles Juarranz; Yolanda Gilaberte
Journal:  Int J Mol Sci       Date:  2015-10-28       Impact factor: 5.923

2.  Biomarkers of basal cell carcinoma resistance to methyl-aminolevulinate photodynamic therapy.

Authors:  Tamara Gracia-Cazaña; Marta Mascaraque; Silvia Rocío Lucena; Jesús Vera-Álvarez; Salvador González; Ángeles Juarranz; Yolanda Gilaberte
Journal:  PLoS One       Date:  2019-04-24       Impact factor: 3.240

Review 3.  Treatment of keratinocyte carcinoma in elderly patients - a review of the current literature.

Authors:  A J G Leus; M Frie; M S Haisma; J B Terra; B E C Plaat; R J H M Steenbakkers; G B Halmos; E Rácz
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-03-30       Impact factor: 6.166

4.  Alternatives to Outdoor Daylight Illumination for Photodynamic Therapy--Use of Greenhouses and Artificial Light Sources.

Authors:  Catharina M Lerche; Ida M Heerfordt; Jakob Heydenreich; Hans Christian Wulf
Journal:  Int J Mol Sci       Date:  2016-02-29       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.